Shaliny Kushwaha

Shaliny Kushwaha currently serves as Senior Vice President of Regulatory Affairs and Development Operations at Crossbow Therapeutics, Inc., starting in October 2024. Prior experience includes a tenure at Syndax Pharmaceuticals from March 2016 to October 2024, where Shaliny held multiple leadership roles, including Vice President of Regulatory Affairs and QA, and Executive Director of Regulatory Affairs and Program Management. Earlier positions include Manager of Regulatory Affairs in Oncology at EMD Serono, Inc., and various roles at Infinity Pharmaceuticals, including Senior Associate in Program Management and Clinical Data Analyst. Additional experience includes technical support roles at Verscend and Axis-Shield PoC, as well as volunteer work at Brigham and Women's Hospital and Boston Medical Center. Shaliny holds a B.A. in Biology from Boston University College of Arts and Sciences, completed in 2009.